guidance
-
Financial
MiMedx Provides 2016 Guidance With Forecasted Revenue Growth In Excess Of 30% And Operating Earnings Growth Of 80% Or Greater
MARIETTA, Ga., Dec. 16, 2015 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected…
Read More » -
Hospitals
The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications
FDA developed this document to provide guidance to industry and FDA staff about current review practices for premarket notification (510(k))…
Read More » -
Medtronic cuts 2011 guidance on weaker demand
Medtronic Inc., the world’s largest medical device maker, reported fiscal first–quarter earnings Tuesday in line with Wall Street expectations, but…
Read More »